Follow The Filings

GPCR position history

The shares of Structure Therapeutics (GPCR) that DAFNA Capital Management LLC reported in each quarter’s 13F.

Equity, SPONSORED ADS

Shares held by quarter

New Add Reduce Exit

  1. 2024 Q2: 5,000 shares, $196K, 0.05% of portfolio, New
  2. 2024 Q3: 34,000 shares, $1.5M, 0.35% of portfolio, Add +580.0%
  3. 2024 Q4: 35,500 shares, $963K, 0.24% of portfolio, Add +4.4%
  4. 2025 Q1: 59,000 shares, $1M, 0.29% of portfolio, Add +66.2%
  5. 2025 Q2: 59,000 shares, $1.2M, 0.34% of portfolio
  6. 2025 Q3: 59,000 shares, $1.7M, 0.41% of portfolio
  7. 2025 Q4: 37,000 shares, $2.6M, 0.60% of portfolio, Reduce −37.3%
  8. 2026 Q1: 46,500 shares, $2.2M, 0.51% of portfolio, Add +25.7%
  9. 2026 Q2: 46,500 shares, $2.5M, 0.48% of portfolio
Holdings date Value % of holdings Shares Filing date All 13F holders